Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Sep 14, 2006

30339_dirs_2006-09-14_94683f79-5f4c-4f84-a94d-89971cd1c4af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-09-12

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-09-12 Common Stock M 49381 $13.9925 Acquired 301494.4743 Direct
2006-09-12 Common Stock F 29968 $41.3900 Disposed 271526.4743 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-09-12 Stock Option (Right to Buy) $13.9925 M 49381 Disposed 2012-04-30 Common stocks (49381.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 780.5432 Indirect
Common Stock 14792.5621 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.